SR-4233 (Tirapazamine) acts as an uncoupler of oxidative phosphorylation in human MCF-7 breast carcinoma cells
- 14 October 1994
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 85 (2), 195-203
- https://doi.org/10.1016/0304-3835(94)90275-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Lack of complications in long-term survivors after treatment with fluosolR and oxygen as an adjuvant to radiation therapy for high-grade brain tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumoursBritish Journal of Cancer, 1993
- Metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) by purified DT-diaphorase under aerobic and anaerobic conditionsBiochemical Pharmacology, 1993
- Tumor tissue oxygenation as evaluated by computerized-po2-histographyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The clinical relevance of tumour hypoxiaEuropean Journal of Cancer and Clinical Oncology, 1990
- Evaluation of oxygen diffusion distances in human breast cancer xenografts using tumor-specific in vivo data: Role of various mechanisms in the development of tumor hypoxiaInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- The hypoxic tumor cell: A target for selective cancer chemotherapyBiochemical Pharmacology, 1980
- Mapping of metabolites in whole animals by 31P NMR using surface coilsNature, 1980
- Analogs of 3-amino-7-chloro-1,2,4-benzotriazine 1-oxide as antimalarial agentsJournal of Medicinal Chemistry, 1968